Compare · HUM vs MDXH
HUM vs MDXH
Side-by-side comparison of Humana Inc. (HUM) and MDxHealth SA (MDXH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HUM and MDXH operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $51.90B, about 901.1x MDXH ($57.6M).
- Over the past year, HUM is up 45.6% and MDXH is down 95.0% - HUM leads by 140.6 points.
- HUM has been more active in the news (12 items in the past 4 weeks vs 5 for MDXH).
- HUM has more recent analyst coverage (25 ratings vs 7 for MDXH).
- Company
- Humana Inc.
- MDxHealth SA
- Price
- $413.06-4.40%
- $0.21-65.85%
- Market cap
- $51.90B
- $57.6M
- 1M return
- +7.44%
- -69.62%
- 1Y return
- +45.59%
- -95.01%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 12
- 5
- Recent ratings
- 25
- 7
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
MDxHealth SA
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
Latest HUM
- Humana Announces New Strategic Joint Venture with BlackRock to Manage CenterWell Senior Primary Care Clinics
- SEC Form 8-K filed by Humana Inc.
- Humana Inc. to Release Third Quarter 2026 Results on November 6, 2026
- Humana upgraded by Raymond James with a new price target
- After a Record-Setting Week, Wall Street Turns to Inflation Data and the First Big Earnings Reports
- Humana upgraded by Robert W. Baird with a new price target
- Humana Announces Improved CMS Star Ratings with 95 Percent of Medicare Advantage Members in 4-Star or Above Plans for 2027
- SEC Form 8-K filed by Humana Inc.
- Humana upgraded by Cantor Fitzgerald with a new price target
- Humana Generates Nearly $20 Billion in Economic Impact Across Kentucky, New Report Finds
Latest MDXH
- MDxHealth SA downgraded by Lake Street with a new price target
- MDxHealth SA downgraded by Craig Hallum
- SEC Form 6-K filed by MDxHealth SA
- Amendment: SEC Form SCHEDULE 13D/A filed by MDxHealth SA
- MDxHealth Announces Preliminary Third Quarter 2026 Revenue and Suspends Full-Year 2026 Revenue Guidance
- SEC Form 144 filed by MDxHealth SA
- SEC Form 6-K filed by MDxHealth SA
- Amendment: SEC Form SCHEDULE 13G/A filed by MDxHealth SA
- Director Mvm Partners, Llc bought $1,000,000 worth of Ordinary Shares (2,202,643 units at $0.45) (SEC Form 4)
- SEC Form SCHEDULE 13D filed by MDxHealth SA